JPS5989690A - ７−アシルアミノ−３−ビニルセフアロスポラン酸誘導体、その製法およびそれを含有する抗菌剤 - Google Patents

７−アシルアミノ−３−ビニルセフアロスポラン酸誘導体、その製法およびそれを含有する抗菌剤

Info

Publication number
JPS5989690A
JPS5989690A JP58184037A JP18403783A JPS5989690A JP S5989690 A JPS5989690 A JP S5989690A JP 58184037 A JP58184037 A JP 58184037A JP 18403783 A JP18403783 A JP 18403783A JP S5989690 A JPS5989690 A JP S5989690A
Authority
JP
Japan
Prior art keywords
group
compound
salt
general formula
vinyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP58184037A
Other languages
English (en)
Japanese (ja)
Inventor
Takao Takatani
高谷　隆男
Hisashi Takasugi
高杉　寿
Takashi Masugi
馬杉　峻
Hideaki Yamanaka
秀昭 山中
Koji Kawabata
浩二 川端
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fujisawa Pharmaceutical Co Ltd
Original Assignee
Fujisawa Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fujisawa Pharmaceutical Co Ltd filed Critical Fujisawa Pharmaceutical Co Ltd
Publication of JPS5989690A publication Critical patent/JPS5989690A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP58184037A 1982-09-30 1983-09-30 ７−アシルアミノ−３−ビニルセフアロスポラン酸誘導体、その製法およびそれを含有する抗菌剤 Pending JPS5989690A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42897082A 1982-09-30 1982-09-30
US428970 1982-09-30

Publications (1)

Publication Number Publication Date
JPS5989690A true JPS5989690A (ja) 1984-05-23

Family

ID=23701196

Family Applications (2)

Application Number Title Priority Date Filing Date
JP58184036A Granted JPS5989689A (ja) 1982-09-30 1983-09-30 ７−置換−３−ビニル−３−セフエム化合物、その製法およびそれを含有する抗菌剤
JP58184037A Pending JPS5989690A (ja) 1982-09-30 1983-09-30 ７−アシルアミノ−３−ビニルセフアロスポラン酸誘導体、その製法およびそれを含有する抗菌剤

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP58184036A Granted JPS5989689A (ja) 1982-09-30 1983-09-30 ７−置換−３−ビニル−３−セフエム化合物、その製法およびそれを含有する抗菌剤

Country Status (5)

Country Link
JP (2) JPS5989689A (de)
BE (1) BE897864A (de)
HK (1) HK92187A (de)
MX (1) MX8670A (de)
ZA (1) ZA836918B (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935508A (en) * 1988-08-23 1990-06-19 Bristol-Myers Company Process for cephem prodrug esters
JP4544692B2 (ja) * 2000-04-13 2010-09-15 大塚化学株式会社 ３−ビニル−セフェム化合物の製造方法
KR100451672B1 (ko) * 2001-06-05 2004-10-08 한미약품 주식회사 결정성 세프디니르 산부가염, 이의 제조방법 및 이를이용한 세프디니르의 제조방법
ITMI20020913A0 (it) * 2002-04-29 2002-04-29 Acs Dobfar Spa Nuova forma cristallina del cefdinir
US20060069079A1 (en) * 2004-09-27 2006-03-30 Sever Nancy E Stable amorphous cefdinir
TR200909784A1 (tr) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Yeni sefdinir tuzları
WO2011078828A1 (en) 2009-12-25 2011-06-30 Mahmut Bilgic Pharmaceutical composition with high purity
WO2011078830A1 (en) 2009-12-25 2011-06-30 Bilgic Mahmut Rapidly dispersing effervescent formulation
TR200909785A1 (tr) 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar.
TR201000686A1 (tr) 2010-01-29 2011-08-22 B�Lg�� Mahmut Bakteriyel enfeksiyonların tedavisinde suda çözünebilir sefdinir ve klavulanik asit formülasyonları.@
WO2011139249A2 (en) 2010-05-04 2011-11-10 Mahmut Bilgic Pharmaceutical composition comprising cefdinir
TR201010860A2 (tr) 2010-11-05 2012-05-21 Bi̇lgi̇ç Mahmut Sefdinir formulasyonları için üretim yöntemi.
TR201009165A2 (tr) 2010-11-05 2012-05-21 Bi̇lgi̇ç Mahmut Sefdinir içeren tabletler
TR201010859A2 (tr) 2010-11-05 2012-05-21 Bi̇lgi̇ç Mahmut Sefdinir içeren tablet formları.
TR201009166A2 (tr) 2010-11-05 2012-05-21 Bi̇lgi̇ç Mahmut Sefdinir içeren farmasötik bileşim için üretim yöntemi
TR201010212A2 (tr) 2010-12-08 2012-06-21 Bi̇lgi̇ç Mahmut Sefdinir içeren katı oral dozaj formu.
WO2013095313A1 (en) 2011-12-19 2013-06-27 Mahmut Bilgic Pharmaceutical formulations comprising cefdinir
CN112321444A (zh) * 2020-09-17 2021-02-05 江西邦浦医药化工有限公司 一种4-溴-3-氧代-n-苯基丁酰胺的合成方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5321192A (en) * 1976-08-10 1978-02-27 Takeda Chem Ind Ltd Cephalosporin derivatives and their preparation
JPS5686187A (en) * 1979-11-19 1981-07-13 Fujisawa Pharmaceut Co Ltd 7-acylamino-3-vinylcephalosporanic acid derivative and its preparation
JPS57156495A (en) * 1981-03-23 1982-09-27 Kyoto Yakuhin Kogyo Kk Cephalosporin derivative and remedy for microbism used in oral administration

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5321192A (en) * 1976-08-10 1978-02-27 Takeda Chem Ind Ltd Cephalosporin derivatives and their preparation
JPS5686187A (en) * 1979-11-19 1981-07-13 Fujisawa Pharmaceut Co Ltd 7-acylamino-3-vinylcephalosporanic acid derivative and its preparation
JPS57156495A (en) * 1981-03-23 1982-09-27 Kyoto Yakuhin Kogyo Kk Cephalosporin derivative and remedy for microbism used in oral administration

Also Published As

Publication number Publication date
JPH0149273B2 (de) 1989-10-24
BE897864A (fr) 1984-03-29
ZA836918B (en) 1984-05-30
JPS5989689A (ja) 1984-05-23
HK92187A (en) 1987-12-11
MX8670A (es) 1993-10-01

Similar Documents

Publication Publication Date Title
JPS5989690A (ja) ７−アシルアミノ−３−ビニルセフアロスポラン酸誘導体、その製法およびそれを含有する抗菌剤
KR910005833B1 (ko) 피리돈 카복실산 유도체 및 이의 염, 이의 제조방법 및 이를 함유하는 항균제
EP3080117B1 (de) Imidazopyridinderivate als modulatoren der tnf-aktivität
US20050215781A1 (en) Novel polymorph of cefdinir
DK172077B1 (da) 6-Fluor-7-(4-(5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl-1-piperazinyl)-4-oxo-4H-(1,3)thiazeto(3,2-a)quinolin-3-carboxylsyre-derivater, fremgangsmåde til fremstilling deraf samt farmaceutiske præparater indeholdende disse forbindelser
TWI568731B (zh) 抗菌之經環戊［ｃ］吡咯取代的３，４－二氫－１ｈ－［１，８］萘啶酮類
US20050080255A1 (en) Crystalline cefdinir potassium dihydrate
WO2015086521A1 (en) Tetrahydroimidazopyridine derivatives as modulators of tnf activity
US4496562A (en) 7-Substituted-3-cephem-4-carboxylic acid esters
JPH02142790A (ja) ２−置換エルゴリン、それを含有するパーキンソン病を治療するための医薬品、ならびに当該化合物を製造するための方法および中間物質
JP2688711B2 (ja) ベンゾヘテロ環化合物
DK162718B (da) Analogifremgangsmaade til fremstilling af 7-substitueret-3-vinyl-3-cephemforbindelser
WO2005090360A1 (en) Novel polymorph of cefdinir
JPS6360031B2 (de)
WO2003002532A1 (en) Cyclic diamine compounds having fused-ring groups
EP0503949B1 (de) Verfahren zur Herstellung von 9-deoxo-9(z)-hydroxyiminoerythromycin A
WO2006018807A1 (en) Crystalline forms of cefdinir
JPH0570474A (ja) ９−デオキソ−９（ｚ）−ヒドロキシイミノエリスロマイシンａおよびそのｏ−誘導体
JP2777661B2 (ja) ベンゾヘテロ環化合物
TW201211048A (en) Compounds with antibacterial activity against Clostridium
JPH03505587A (ja) ８β―置換されたエルゴリン、その製法及びその使用
GB2025395A (en) Therapeutically active substituted dibenzyl ethers
EP1828208A2 (de) Kristalline form eines cefdinir-cäsiumsalzes
HUT59126A (en) Process for producing 3-(1h-indazol-3-yl)-4-pyridineamines and pharmaceutical compositions comprising same
KR20080040645A (ko) 항부정맥 전구체 화합물, 합성 방법 및 사용 방법